Cryofocus Medtech (Shanghai) Co (HKSE:06922) Gross-Profit-to-Asset % : 10.15% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Cryofocus Medtech (Shanghai) Co's annualized Gross Profit for the quarter that ended in Jun. 2023 was HK$32.02 Mil. Cryofocus Medtech (Shanghai) Co's average Total Assets over the quarter that ended in Jun. 2023 was HK$315.62 Mil. Therefore, Cryofocus Medtech (Shanghai) Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 10.15%.

Cryofocus Medtech (Shanghai) Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Gross-Profit-to-Asset % Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

6.24

10.24

6.82

11.65

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			-	5.86	7.82	10.15	13.98

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Gross-Profit-to-Asset % falls into.

Cryofocus Medtech (Shanghai) Co Gross-Profit-to-Asset % Calculation

Cryofocus Medtech (Shanghai) Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	21.622	/	( (283.701	+	350.495)	/ 2 )
	=	21.622	/	317.098
	=	6.82 %

Cryofocus Medtech (Shanghai) Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	32.022	/	( (350.495	+	280.749)	/ 2 )
	=	32.022	/	315.622
	=	10.15 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Cryofocus Medtech (Shanghai) Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines